Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 2, n° 4
pages 295-302 (avril 1980)
Doi : 10.1016/S0190-9622(80)80041-7
Clinical and laboratory studies

Erythema dyschromicum perstans

Jaime A. Tschen, M.D. 1, 2, 3, Eduardo A. Tschen, M.D. 1, 2, 3, Malcolm H. McGavran, M.D. 1, 2, 3,
1 From the Department of Pathology, Baylor College of Medicine, USA 
2 The Division of Dermatology, Roosevelt Hospital, Guatemala City, USA 
3 University of San Carlos of Guatemala, USA 

4Reprint requests to: Dr. Malcolm H. McGavran, MS#205, Methodist Hospital, 6516 Bertner, Houston, TX 77030.

Erythema dyschromicum perstans (EDP) was first described in 1957, and electron microscopic studies were reported in 1969. Herein, we describe five cases and compare light and electron microscopic findings, direct and indirect immunofluorescence, and dopa-positive melanocyte counts between normal and affected skin. The results indicate that EDP is a clinically characteristic disorder with a lichenoid reaction in its active phase. This lichenoid reaction leads to a pronounced incontinence of pigment and to decreased numbers of melanocytes and of tyrosinase activity in the involved epidermis. These findings support the suggestion that EDP and lichen planus pigmentosus are possibly the same entity. Direct inmunofluorescence and fine structural studies show similar findings to lichen planus. Patients have low-titer antibodies to extranuclear basal cell components.

The full text of this article is available in PDF format.

Top of the page

© 1980  American Academy of Dermatology, Inc.. Published by Elsevier Masson SAS@@#104157@@